Axa S.A. Invests $1.06 Million in Nu Skin Enterprises, Inc. (NYSE:NUS)

Axa S.A. bought a new stake in Nu Skin Enterprises, Inc. (NYSE:NUSFree Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 100,634 shares of the company’s stock, valued at approximately $1,061,000.

Other hedge funds have also recently made changes to their positions in the company. Caxton Associates LP grew its stake in Nu Skin Enterprises by 155.4% during the 2nd quarter. Caxton Associates LP now owns 48,842 shares of the company’s stock valued at $515,000 after purchasing an additional 29,718 shares during the last quarter. Public Sector Pension Investment Board lifted its holdings in shares of Nu Skin Enterprises by 6.5% during the second quarter. Public Sector Pension Investment Board now owns 109,239 shares of the company’s stock worth $1,151,000 after purchasing an additional 6,710 shares during the period. Ensign Peak Advisors Inc boosted its position in Nu Skin Enterprises by 9.0% in the second quarter. Ensign Peak Advisors Inc now owns 19,976 shares of the company’s stock valued at $211,000 after buying an additional 1,650 shares during the last quarter. Pacer Advisors Inc. acquired a new position in Nu Skin Enterprises in the 2nd quarter worth approximately $25,230,000. Finally, Canada Pension Plan Investment Board purchased a new position in Nu Skin Enterprises during the 2nd quarter worth approximately $47,000. 82.84% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Citigroup dropped their price objective on shares of Nu Skin Enterprises from $14.00 to $11.50 and set a “neutral” rating on the stock in a report on Friday, August 9th. StockNews.com raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, September 6th. Finally, DA Davidson decreased their price objective on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating for the company in a report on Monday, August 12th. Three analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Nu Skin Enterprises presently has an average rating of “Hold” and an average target price of $16.50.

Check Out Our Latest Analysis on NUS

Nu Skin Enterprises Stock Performance

Shares of NYSE NUS opened at $7.11 on Wednesday. The company has a market capitalization of $353.13 million, a PE ratio of -118.50 and a beta of 1.13. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.33 and a current ratio of 2.12. The company’s fifty day moving average price is $8.99 and its 200 day moving average price is $11.16. Nu Skin Enterprises, Inc. has a 1 year low of $6.72 and a 1 year high of $21.02.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last posted its earnings results on Thursday, August 8th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.04. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. The business had revenue of $439.10 million for the quarter, compared to analyst estimates of $431.87 million. During the same period in the prior year, the company posted $0.54 EPS. The company’s revenue for the quarter was down 12.2% on a year-over-year basis. On average, research analysts predict that Nu Skin Enterprises, Inc. will post 0.78 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 11th. Stockholders of record on Friday, August 30th were given a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.38%. The ex-dividend date was Friday, August 30th. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently -400.00%.

Nu Skin Enterprises Profile

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

See Also

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUSFree Report).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.